Mereto di Tomba, Italy

Dipharma S.p.a.


USPTO Granted Patents = 25

% Expired Patents = 80.0

Trademarks = 2

Forward Citations = 107

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal Graziano Castaldi (19 out of 69 patents)

silverMedal Pietro Allegrini (14 out of 65 patents)

bronzeMedal Gabriele Razzetti (12 out of 35 patents)

4.  Alberto Bologna (6 out of 8 patents)

5.  Vittorio Lucchini (6 out of 10 patents)

6.  Simone Mantegazza (4 out of 8 patents)

7.  Giuseppe Barreca (3 out of 25 patents)

8.  Tiziano Scubla (3 out of 5 patents)

9.  Fausto Gorassini (3 out of 4 patents)

10.  Nevio Francescutti (3 out of 3 patents)

11.  Roberto Rossi (3 out of 4 patents)

12.  Antonio Tarquini (3 out of 5 patents)

13.  Lino Colombo (2 out of 3 patents)

14.  Marcello Rasparini (2 out of 10 patents)

15.  Domenico Magrone (2 out of 7 patents)


Core Competencies:
Pramipexole
1,4-Butanediol Mononitrate
Telmisartan
Valsartan
Tolterodine
Phenyltetrazole
Adapalene
Clopidogrel
Modafinil
Terbinafine
Benzylimidazole
Pantoprazole

25 patents:

Dipharma S.p.a. is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on innovative solutions for various therapeutic areas, emphasizing quality and compliance with international standards. Based in Mereto di Tomba, Italy, Dipharma leverages advanced technologies and a commitment to research to enhance its product offerings and support the global healthcare market.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Dipharma S.p.a.
25 Patents

#1 in Mereto di Tomba

#376 in Italy

#25,651 in the World

Mereto di Tomba, IT
Mereto di Tomba, Italy
Forward Citations = 107

28 inventors:

Please report any incorrect information to [email protected]
Loading…